Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

    Funding available for preclinical studies in rare diseases to show effectiveness of proposed treatments for potential further development into clinical trials.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Forecast for Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

    This grant will fund research to improve clinical trial readiness for rare diseases by developing tools like biomarkers and outcome measures to help move new treatments or diagnostics toward successful trials.

    HHS-NIH11Due Feb 17, 2027$275,000

    Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

    This grant funds innovative natural history studies to advance medical product development and address unmet needs in rare diseases by generating high-quality, interpretable data.

    HHS-FDADue Jan 7, 2028$2,400,000

    Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

    This grant funds innovative natural history studies to improve understanding and support medical product development for rare diseases with unmet needs.

    HHS-FDA$400,000Forecasted

    Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

    Funds clinical trials testing new or existing treatments to improve care and expand approved uses for rare diseases with unmet medical needs.

    HHS-FDAForecasted

    Translational Neural Devices (R61/R33 - Clinical Trial Optional)

    Encourages translational activities and small clinical studies for neural devices to address disorders affecting the nervous system; includes prototype development, safety testing, and clinical validation.

    HHS-NIH11Due Jan 28, 2027